Delivery Order SPE2DB22D2206-SPE2DB26FDT13
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $1,385.52 for 30 tablets of Orgovyx 120 mg on August 19, 2025, with completion expected by September 10, 2025. The contract, which carries no set-aside designation, will be performed at the company's corporate office in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing a specialized pharmaceutical commodity within the...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of May 12, 2025. This non-set-aside award was issued on April 21, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical product the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, valued at $8,313.12, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, demonstrating the agency's ongoing need...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets on May 7, 2025, with an ultimate completion date of May 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is not subject to a set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $24,939.36 to AmerisourceBergen Drug Corp for 30-unit supplies of Orgovyx 120 mg tablets, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on October 23, 2025, with completion expected by November 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of advanced prostate...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDT13Delivery Order
The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of November 13, 2025. This competitive award, issued on October 22, 2025, carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical product that AmerisourceBergen supplies through its federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capacity to fulfill federal medical procurement requirements through open competition, combined with its significant role as a pharmaceutical prime vendor for the Defense Health Agency and other government healthcare systems, underscores its critical position within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/22/25 |